Skip to main content
. 2016 Jan 18;3(5):465–471. doi: 10.1002/mdc3.12309

Figure 2.

Figure 2

Frequency of mutation carriers in the deep brain stimulation (DBS) and non‐DBS groups. LRRK2, leucine‐rich repeat kinase 2; GBA, glucocerebrosidase; PRKN, parkin; WT, wild‐type (GBA: DBS vs. non‐DBS, P = 0.26; LRRK2: DBS vs. non‐DBS, P = 0.58; PRKN: DBS vs. non‐DBS, P = 0.13).